Guru Ownership Trend
Guru Analysis for NewAmsterdam Pharma Company N.V. (NAMS)
NewAmsterdam Pharma Company N.V. (NAMS), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q1 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $335.63 M.
Top institutional holders include Andreas Halvorsen and Stanley Druckenmiller.
Institutional sentiment is currently Bullish. This is evidenced by a $8.93 M net inflow during the quarter.
Recent activity highlights Lee Ainslie who increased their stake by 15.4%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q1 2026)
Guru Consensus (Q1 2026)
FAQs for NewAmsterdam Pharma Company N.V. (NAMS)
Major holders include Andreas Halvorsen ($134.56 M), Stanley Druckenmiller ($98.28 M), Lee Ainslie ($69.99 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 9.47 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $8.93 M, with 2 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 0 managers trimmed their positions, while 1 fully exited NAMS. The total reported sell value was $420,960.
Yes, 0 managers opened new positions in NAMS, and 2 increased their existing holdings. The total reported buy value was $9.36 M.